Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer

Karla Rubio, Addi J. Romero‐Olmedo, Pouya Sarvari, Guruprasadh Swaminathan, Vikas Ranvir, Diana G. Rogel-Ayala, Julio Cordero, Stefan Günther, Aditi Mehta, Birgit Bassaly,

Theranostics · 2023 · 40 citations · 78 references

DOIFull text

Open access

Concepts

Abstract

We uncovered a mechanism of ITGB2-mediated EGFR activation in SCLC that explains EGFR-inhibitor resistance independently of EGFR mutations, suggesting the development of therapies targeting ITGB2 for patients with this extremely aggressive lung cancer type.

References

78